| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/27/2006 | WO2006077020A2 Method for the specific or unspecific separation of cells and/or viruses from aqueous media and use thereof |
| 07/27/2006 | WO2006077012A2 USE OF LXR LIGANDS FOR THE MODULATION OF DENDRITIC CELLS (DCs) |
| 07/27/2006 | WO2006076905A2 Method for detecting and removing endotoxin |
| 07/27/2006 | WO2006076825A1 A method for detecting the pork quality traits and carcass traits |
| 07/27/2006 | WO2006076758A1 Instrumentation probe for in situ measurement and testing of seabed |
| 07/27/2006 | WO2006058159A3 Methods and compositions for the ex vivo high-throughput detection of protein/protein interactions |
| 07/27/2006 | WO2006055753A3 Fluorescence polarization assay for determining histidine decarboxylase activity |
| 07/27/2006 | WO2006047662A9 Method and apparatus for sediment characterization |
| 07/27/2006 | WO2006045799A3 Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions |
| 07/27/2006 | WO2006044643A3 Anti-cd70 antibody and its use for the treatment and prevention of cancer and immune disorders |
| 07/27/2006 | WO2006044523A3 Biomarkers for use in vessel disorders |
| 07/27/2006 | WO2006037072A3 Latex particulates with epoxide functional groups |
| 07/27/2006 | WO2006031912A3 Busulfan immunoassay |
| 07/27/2006 | WO2006031363A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/27/2006 | WO2006029052A3 Methods for assessing atherosclerosis |
| 07/27/2006 | WO2006020730A3 Ileitis diagnostic assay |
| 07/27/2006 | WO2006012614A8 Fabrication methods and multifunctional substrate materials for chemical and biological analysis in microfluidic systems |
| 07/27/2006 | WO2005124343A3 Methods for modulating bone tissue formation, orthogenic agents and pharmaceutical compositions |
| 07/27/2006 | WO2005123119A3 Administration of neutral endopeptidase to treat inflammatory bowel disease |
| 07/27/2006 | WO2005114206A3 Diagnostics and therapeutics for diseases associated with serotonin 5-ht5a receptor (5ht5a) |
| 07/27/2006 | WO2005113800A3 Method and device for monitoring aspirin response |
| 07/27/2006 | WO2005110459A3 Method of inducing immunity against stratum corneum chymotrytic enzyme |
| 07/27/2006 | WO2005108599A3 Compositions and methods for treatment of protein misfolding diseases |
| 07/27/2006 | WO2005102038A3 Expression of polypeptides in rod outer segment membranes |
| 07/27/2006 | WO2005100600A3 Ionic based sensing for identifying genomic sequence variations and detecting mismatch base pairs, such as single nucleotide polymorphisms |
| 07/27/2006 | WO2005097187A3 Methods of preventing uvb-induced skin damage |
| 07/27/2006 | WO2005092922A3 Antigen of the pm-2 antibody and use thereof |
| 07/27/2006 | WO2005086965A3 A process and apparatus for improving and controlling the curing of natural and synthetic moldable compounds |
| 07/27/2006 | WO2005076009A3 Method for identifying and quantifying of tumour-associated peptides |
| 07/27/2006 | WO2005070020A3 Gefitinib sensitivity-related gene expression and products and methods related thereto |
| 07/27/2006 | WO2005062979A3 Immunoassays, haptens, immunogens and antibodies for anti-hiv therapeutics |
| 07/27/2006 | WO2005060725A8 Nucleic acid amplification methods |
| 07/27/2006 | WO2005060675A3 Novel spliced 5-ht1a receptors and methods, kits, and uses relating thereto |
| 07/27/2006 | WO2005020902A3 Compositions and methods for treating and diagnosing irritable bowel syndrome |
| 07/27/2006 | WO2005017692A3 An advanced databasing system for chemical, molecular and cellular biology |
| 07/27/2006 | WO2005003732A3 Diagnostic test for analytes in a sample |
| 07/27/2006 | WO2004113555A3 Identifying, monitoring, and sorting genetically modified plant portions |
| 07/27/2006 | WO2004062483A3 Cancer comprehensive method for identifying cancer protein patterns and determination of cancer treatment strategies |
| 07/27/2006 | WO2004039948A3 Actriib fusion polypeptides and uses therefor |
| 07/27/2006 | WO2004019875A3 Non-invasive methods to identify agents for treating pain |
| 07/27/2006 | WO2004005883A3 Secreted and cytoplasmic tumor endothelial markers |
| 07/27/2006 | WO2003085086A3 Motif-grafted hybrid polypeptides and uses thereof |
| 07/27/2006 | US20060168672 B7-like molecules and uses thereof |
| 07/27/2006 | US20060168668 Phosphodiesterase 2a and methods of use |
| 07/27/2006 | US20060168667 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 07/27/2006 | US20060168665 Flourescent proteins as cell type specific reporters |
| 07/27/2006 | US20060167637 System and methods for optimized drug delivery and progression of diseased and normal cells |
| 07/27/2006 | US20060167231 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/27/2006 | US20060167227 Truncated tau proteins |
| 07/27/2006 | US20060166998 Pyrrolo[1,2-B]pyridazine compounds and their uses |
| 07/27/2006 | US20060166950 Treatment of neovascularization disorders with squalamine |
| 07/27/2006 | US20060166911 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a) |
| 07/27/2006 | US20060166891 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia |
| 07/27/2006 | US20060166876 Delocalization molecules and use thereof |
| 07/27/2006 | US20060166377 Particle for magnetically induced membrane transport |
| 07/27/2006 | US20060166376 Compositions for use as a signal generation component and methods of using same |
| 07/27/2006 | US20060166375 Microscale diffusion immunoassay utilizing multivalent reactants |
| 07/27/2006 | US20060166374 Method for the visual detection of specific antibodies by the use of lateral flow assays |
| 07/27/2006 | US20060166368 Coumarin-based cyanine dyes for non-specific protein binding |
| 07/27/2006 | US20060166367 Protein assay method and test device |
| 07/27/2006 | US20060166366 preparing a measurement sample by mixing a canine or feline blood sample with a lysing reagent, classifying the leukocytes, on the basis of the measured data, into a first group consisting essentially of lymphocytes, a second group consisting essentially of neutrophils and monocytes etc. |
| 07/27/2006 | US20060166350 Method of detecting an analyte in a fluid |
| 07/27/2006 | US20060166333 Testing for human papillomavirus or host genetic markers by applying an absorbent and porous material onto introitus of a female patient to collect vaginal discharge, either briefly as an imprint or swab; air drying; disposable underwear; nucleic acid amplification; diagnosis |
| 07/27/2006 | US20060166325 Glial cell line-derived neurotrophic factor receptor |
| 07/27/2006 | US20060166311 Novel notch-origin polypeptides and biomarkers and reagents using the same |
| 07/27/2006 | US20060166300 Method of measuring homocysteine |
| 07/27/2006 | US20060166298 Assay system for simultaneous detection and measurement of multiple modified cellular proteins |
| 07/27/2006 | US20060166297 solid phase; antitumor agents |
| 07/27/2006 | US20060166296 Standard compound for immunoassay for dioxin and method of immunoassay for dioxin |
| 07/27/2006 | US20060166295 Method for determination of likelihood of occurrence of preterm labor in pregnant females |
| 07/27/2006 | US20060166294 Apoptosis marker antibodies and methods of use |
| 07/27/2006 | US20060166293 Zinc alpha-2-glycoprotein as indicator of cancer |
| 07/27/2006 | US20060166292 Methods of diagnosing and treating prostate cancer |
| 07/27/2006 | US20060166291 KID31 and antibodies that bind thereto |
| 07/27/2006 | US20060166290 Primary central nervous system tumor specific BEHAB isoforms |
| 07/27/2006 | US20060166289 Method for analyzing tumor agressivity comprising measurement of polymerized actin |
| 07/27/2006 | US20060166288 Assay for the screening of compounds acting through erbb-2 |
| 07/27/2006 | US20060166287 Method for Identifying compounds for suppressing metastasizing tumor cells |
| 07/27/2006 | US20060166286 Methods and compositions for tagging via azido substrates |
| 07/27/2006 | US20060166285 Charged permeation layers for use on active electronic matrix devices |
| 07/27/2006 | US20060166284 used to form a non-thrombogenic coating on the surface of a medical device; antibodies bind with greater affinity to the factor VIIa/tissue factor (FVIIa/TF) complex than to tissue factor (TF) alone |
| 07/27/2006 | US20060166283 Means for detecting neurodegenerative processes and applications of same |
| 07/27/2006 | US20060166282 Methods and compositions for screening cell binding molecules |
| 07/27/2006 | US20060166281 Tissue targeted therapy; identifying antitumor agents specific to transphosphorylase domain of c-kit; interleulin-3 cell targeting |
| 07/27/2006 | US20060166280 analyzing oxidized amino acids |
| 07/27/2006 | US20060166279 Sea-trosy and related methods |
| 07/27/2006 | US20060166277 Nucleic acids and polypeptides useful for diagnosing and treating complications of pregnancy |
| 07/27/2006 | US20060166276 Method of diagnosis and agents useful for same |
| 07/27/2006 | US20060166275 Amyloid beta protein (globular assembly and uses thereof) |
| 07/27/2006 | US20060166274 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 07/27/2006 | US20060166273 Enhanced methods for crystallographic structure determination employing hydrogen exchange analysis |
| 07/27/2006 | US20060166272 Method of adjudicating on acute aortic dissection and reagent for adjudication |
| 07/27/2006 | US20060166271 Non-radioactive schilling test |
| 07/27/2006 | US20060166270 Detection of demyelination |
| 07/27/2006 | US20060166269 Method of measuring binding site on plasma protein of plasma protein-binding drug and method of measuring plasma protein mutation |
| 07/27/2006 | US20060166268 Diagnosis of glaucoma by complex autoantibody repertoires in body fluids |
| 07/27/2006 | US20060166267 Facilitates the isolation of proteins from the cell nucleus interior as an independent fraction by separating the complete proteome into partial proteomes and thus makes this fraction available for further analyses for the first time in adequate purity and quality |
| 07/27/2006 | US20060166266 Screening method for regulatory enzymes employing tribrid (tri-hybrid) system |
| 07/27/2006 | US20060166265 Survivin-binding proteins, encoding nucleic acids, and methods of use |
| 07/27/2006 | US20060166263 Randomized libraries of zinc finger proteins |